Home » Topics » Regulatory » Patents

Patents
RSS

Novel antiulcer agents reported by Arax

Nov. 1, 1996

Merck & Co. describes CCK/gastrin antagonists

Nov. 1, 1996

Terumo discloses agents with activity against H. pylori

Nov. 1, 1996

Factor Xa/thrombin inhibitors from Roche

Nov. 1, 1996

Berlex discloses factor Xa inhibitors

Nov. 1, 1996

cGMP-PDE inhibitors described by Sanofi Winthrop

Nov. 1, 1996

Hoechst claims new antiarrhythmic agents

Nov. 1, 1996

New dual ACE/NEP inhibitors claimed by Bristol-Myers Squibb

Nov. 1, 1996

Ono discloses cGMP-PDE/TxA2 synthase inhibitors

Nov. 1, 1996

New antiallergic agents from Takeda

Nov. 1, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...